Content
Exxon Buys Denbury For $4.9 Billion In "Hard To Replicate" CO2 Pipeline Push
Article By:
Tyler Durden
Read
Thursday, July 13, 2023 12:59 PM EDT
Denbury’s key asset is 1,300 miles of pipelines dedicated to transporting CO2.
Week In Review: AstraZeneca Considers Spinning Off China Ops Into Separate Company
Article By:
ChinaBio® Today
Read
Saturday, June 24, 2023 3:57 PM EDT
Deals, financings, trials and approvals for the week ending June 23.
Dispersion Is The Name Of The Game
Article By:
AllAboutAlpha
Read
Monday, June 19, 2023 1:10 AM EDT
Overall, it is fair to say that Private Equity activity is cooling down, but not falling off a cliff.
Is Manchester United A Summer Buy?
Video By:
Seasonax
Watch
Sunday, June 18, 2023 12:31 AM EDT
Seasonally Manchester United plc has had a decent summer period. MANU share price gained earlier this week on speculation that the club may be about to be sold. However, sales of big clubs are notoriously difficult, and prone to rumors.
In this video: MANU
Chevron’s Financial Discipline
Article By:
Robert Rapier
Read
Monday, May 29, 2023 7:02 AM EDT
On May 22, 2023, Chevron announced that it had entered into a definitive agreement with PDC Energy, Inc. Chevron will acquire all of the outstanding shares of PDC in an all-stock transaction valued at $6.3 billion, or $72 per share.
This Energy Midstream Mega-Deal Will Be A Winner
Article By:
Tony Daltorio
Read
Wednesday, May 24, 2023 8:46 AM EDT
U.S. natural gas pipeline giant ONEOK is set to buy Magellan Midstream Partners, which owns a pipeline network that primarily transports crude oil and refined products for $18.8 billion.
More Thoughts On Oneok And Magellan
Article By:
Simon Lack
Read
Sunday, May 21, 2023 7:18 AM EDT
Wall Street analysts are predisposed to be supportive of management’s M&A activities. Hence the response of sell-side analysts to Oneok’s proposed acquisition of Magellan Midstream is one of mild surprise that stops short of overt criticism.
The FTC, Amgen, And Horizon: A New Hurdle For Biotech Deal Making Or Regulatory Overreach?
Article By:
Bio Deep Dives
Read
Thursday, May 18, 2023 4:13 PM EDT
The FTC suit against Amgen appears to be a clear case of regulatory overreach but what this ultimately means will take time to fully develop.
Cloud Stocks: Analysis Of Amazon’s One Medical Acquisition
Article By:
Sramana Mitra
Read
Friday, May 12, 2023 12:58 PM EDT
Amazon had announced plans to acquire One Medical last year, but the deal was undergoing FTC investigation.
In this article: AMZN
J&J's Kenvue Jumps 20% In Market Debut
Article By:
The Fly
Read
Sunday, May 7, 2023 1:20 PM EDT
Shares of Johnson & Johnson's consumer-health spin-off Kenvue soared 20% in their market debut on Thursday, making it the biggest U.S. IPO in over a year. Under Kenvue's umbrella are widely-known consumer brands like Band-Aid, Tylenol, and Aveeno.
The AT&T Merger With Time Warner: Another Follow-Up
Article By:
Timothy Taylor
Read
Thursday, May 4, 2023 1:04 AM EDT
Back in 2018, AT&T merged with Time Warner. Now, a few years later, we can see what happened.
In this article: T
The State Of The SPAC Market
Article By:
Russell Investments
Read
Thursday, April 27, 2023 10:58 PM EDT
Despite the recent overhype, SPACs have existed for decades and do fulfill an important function in the capital markets.